EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cerebral Small Vessel Disease Outperforms Brain Atrophy as an Imaging Biomarker in Diabetic Retinopathy

Xinyi Shen, Wen Zhang, Xin Li, Xin Zhang iD, Qian Li, Min Wu, Linqing Fu, Jiaming Lu, Zhengyang Zhu, Bing Zhang iD

Journal of Diabetes · 2025

DOI: 10.1111/1753-0407.70058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes, 2025. Verfasst von Xinyi Shen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Cerebral Small Vessel Diseases, Magnetic Resonance Imaging, Brain. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science and Technology Innovation 2030, Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study aimed to examine microvascular lesions and neurodegenerative changes in diabetic retinopathy (DR) compared to type 2 diabetes mellitus (T2DM) without DR (NDR) using structural MRI and to explore their associations with DR.

Methods

243 patients with NDR and 122 patients with DR were included. Participants underwent conventional brain MRI scans, clinical measurements, and fundus examinations. Cerebral small vessel disease (CSVD) imaging parameters were obtained using AI‐based software, manually verified, and corrected for accuracy. Volumes of major cortical and subcortical regions representing neurodegeneration were assessed using automated brain segmentation and quantitative techniques. Statistical analysis included T ‐test, chi‐square test, Mann–Whitney U test, multivariate analysis of variance (MANCOVA), multivariate logistic regression, area under the receiver operating characteristic curve (AUC), and Delong test.

Results

DR group exhibited significant differences in 11 CSVD features. Meanwhile, DR showed an atrophy trend in the frontal cortex, occipital cortex, and subcortical gray matter (GM) compared to NDR. After adjustment, DR patients exhibited greater perivascular spaces (PVS) numbers in the parietal lobe (OR = 1.394) and deep brain regions (OR = 1.066), greater dilated perivascular spaces (DPVS) numbers in the left basal ganglia (OR = 2.006), greater small subcortical infarcts (SSI) numbers in the right hemisphere (OR = 3.104), and decreased left frontal PVS (OR = 0.824), total left DPVS (OR = 0.714), and frontal cortex volume (OR = 0.959) compared to NDR. Further, the CSVD model showed a larger AUC (0.823, 95% CI: 0.781–0.866) than the brain atrophy model (AUC = 0.757, 95% CI: 0.706–0.808).

Conclusion

Microvascular and neurodegeneration are significantly associated with DR. CSVD is a better imaging biomarker for DR than brain atrophy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyCerebral Small Vessel DiseasesMagnetic Resonance ImagingBrainDiabetes Mellitus, Type 2HumansMaleFemaleMiddle AgedAtrophyAgedBiomarkers

Stichwörter der Autor:innen

brain atrophycerebral small vessel diseasediabetic retinopathyneurodegenerationtype 2 diabetes mellitus

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Institute of Medical Imaging and Artificial Intelligence, Nanjing University, Nanjing, China.
  • Medical Imaging Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Department of Radiology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.
  • Institute of Brain Science, Nanjing University, Nanjing, China.

ORCID-Profile: Xin Zhang, Bing Zhang

Förderung

  • National Natural Science Foundation of China
  • National Science and Technology Innovation 2030
  • Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University
  • Jiangsu Funding Program for Excellent Postdoctoral Talent

Zitieren

APA

Shen, X., Zhang, W., Li, X., Zhang, X., Li, Q., Wu, M., Fu, L., Lu, J., Zhu, Z., & Zhang, B. (2025). Cerebral Small Vessel Disease Outperforms Brain Atrophy as an Imaging Biomarker in Diabetic Retinopathy. Journal of Diabetes. https://doi.org/10.1111/1753-0407.70058

Vancouver

Shen X, Zhang W, Li X, Zhang X, Li Q, Wu M, et al. Cerebral Small Vessel Disease Outperforms Brain Atrophy as an Imaging Biomarker in Diabetic Retinopathy. Journal of Diabetes. 2025. doi:10.1111/1753-0407.70058

BibTeX
@article{Shen2025,
  author = {Shen, Xinyi and Zhang, Wen and Li, Xin and Zhang, Xin and Li, Qian and Wu, Min and Fu, Linqing and Lu, Jiaming and Zhu, Zhengyang and Zhang, Bing},
  title = {Cerebral Small Vessel Disease Outperforms Brain Atrophy as an Imaging Biomarker in Diabetic Retinopathy},
  journal = {Journal of Diabetes},
  year = {2025},
  doi = {10.1111/1753-0407.70058}
}
Kostenlos starten →